BloggingStocks has a new home! Daily Finance.
Click here to visit the new home of BloggingStocks!rheumatoid arthritis posts
Feed
"After releasing their 3Q financials. the stock price at Isis Pharmacueticals (ISIS) perked up as their large cash position and deep pipeline have attracted some new investors," notes biotech expert John McCamant.
The editor of The Medical Technology Stock Letter explains, "When investors investigate the ISIS story and all its parts, they come away with an appreciation for all the potential long-term value being created at the company.
Continue reading Isis (ISIS): 'Deep Pipeline, Long-Term Value'
Biogen Idec (BIIB) has made a bit of news the past two days, starting with Thursday's news that William Young is the company's new chairman of the board. BIIB's Bruce Ross will complete his term as director and will step down from the board at BIIB's 2010 shareholder meeting. William Young will take over effective January 1, 2010. Young is a veteran of the biotech industry, as he served with Monogram Biosciences, Genentech (where he was CEO), and Eli Lilly. Continue reading Biogen Idec names new chairman, announces positive drug test results
Well, 9.7% unemployment did not create a ridiculous trading volume day, even though it felt as though the entire trading universe awaited the 4:00 closing bell for the long weekend. Continue reading Closing Bell: The close of the week that wouldn't end (AAPL, ARRY, FNM, TIVO)
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
What's a Realistic Retirement Age?
Farmers Hit the Jackpot in Kansas Oil Boom
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update